|
TFAM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.85149731288948E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.84890003307459E-09 |
| Normal-vs-Stage2 |
6.23899999999677E-05 |
| Normal-vs-Stage3 |
5.90939996936157E-09 |
| Normal-vs-Stage4 |
4.60649962619186E-10 |
| Stage1-vs-Stage2 |
5.807600E-01 |
| Stage1-vs-Stage3 |
4.827800E-01 |
| Stage1-vs-Stage4 |
7.934400E-02 |
| Stage2-vs-Stage3 |
3.368600E-01 |
| Stage2-vs-Stage4 |
6.515600E-02 |
| Stage3-vs-Stage4 |
2.603600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.45010045374761E-10 |
| Normal-vs-AfricanAmerican |
5.787600E-04 |
| Normal-vs-Asian |
1.71189999953469E-08 |
| Caucasian-vs-AfricanAmerican |
7.024200E-01 |
| Caucasian-vs-Asian |
2.349000E-01 |
| AfricanAmerican-vs-Asian |
2.604600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.58669752284391E-11 |
| Normal-vs-Female |
2.68400002223501E-09 |
| Male-vs-Female |
6.164300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.48880000444751E-08 |
| Normal-vs-Age(41-60Yrs) |
2.38809971797593E-10 |
| Normal-vs-Age(61-80Yrs) |
6.39620000297825E-08 |
| Normal-vs-Age(81-100Yrs) |
8.439300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.583800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.956200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.393600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.759800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.739800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.820800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.341000E-01 |
| Classical-VS-Follicular |
7.848200E-02 |
| Classical-VS-Other |
2.385200E-01 |
| Classical-VS-Normal |
1.57939999967383E-08 |
| Tall-VS-Follicular |
8.610400E-01 |
| Tall-VS-Other |
4.871400E-01 |
| Tall-VS-Normal |
3.45209999996765E-06 |
| Follicular-VS-Other |
6.001200E-01 |
| Follicular-VS-Normal |
2.18510000093985E-08 |
| Other-VS-Normal |
1.876980E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.0736999612202E-09 |
| Normal-vs-N1 |
4.57439996992548E-09 |
| N0-vs-N1 |
9.543900E-02 |
|
|
